Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

285
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Listen to Gen Z when it comes to AI in education.

Nature·2026
Same author

Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship.

Transfusion·2026
Same author

An updated checklist of Culicoides Latreille, 1809 biting midges from the highlands of eastern Democratic Republic of the Congo.

Medical and veterinary entomology·2026
Same author

Articulatory Settings of Japanese-English Bilinguals.

Language and speech·2025
Same author

Long-Term Cancer Risk of US Service Members Exposed to Burn Pits in Iraq.

JAMA network open·2025
Same author

Facial Angioedema, Rash, and "Mastitis" in a 31-Year-Old Female.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2025

Related Experiment Video

Updated: May 22, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K

Penile diffuse large B-cell lymphoma in a young man.

Ian Robertson1, Jon Heald2, Daniel Ding3

  • 1Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA ianrobertson415@gmail.com.

BMJ Case Reports
|March 14, 2025
PubMed
Summary

This case study details a rare instance of penile diffuse large B-cell lymphoma (DLBCL) in a young adult. The patient successfully responded to R-CHOP chemotherapy, avoiding radiation therapy.

Keywords:
ChemotherapyUrology

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

1.8K

Related Experiment Videos

Last Updated: May 22, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

1.8K

Area of Science:

  • Hematology
  • Oncology
  • Urology

Background:

  • Penile diffuse large B-cell lymphoma (DLBCL) is an exceptionally rare extranodal non-Hodgkin lymphoma.
  • Primary penile DLBCL typically affects elderly men, with a median age of 69 years.

Purpose of the Study:

  • To report a unique case of stage IE penile DLBCL in a young active-duty service member.
  • To discuss the diagnosis and management of this rare condition in an atypical demographic.

Main Methods:

  • Case presentation of a young male diagnosed with stage IE penile DLBCL, germinal centre B-cell (GCB) subtype.
  • Treatment administered included four cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).
  • Interim positron emission tomography (PET) scan guided the decision to omit radiation therapy.

Main Results:

  • The patient, significantly younger than the typical demographic, achieved a positive response to R-CHOP chemotherapy.
  • Radiation therapy was not administered due to the favorable PET scan results, indicating treatment efficacy.
  • The case highlights successful management of penile DLBCL in an unusual patient profile.

Conclusions:

  • Penile DLBCL, though rare, can occur in younger individuals, challenging typical epidemiological patterns.
  • R-CHOP chemotherapy is an effective treatment option for limited-stage penile DLBCL.
  • PET-guided treatment de-escalation may be feasible in select cases of penile DLBCL, sparing patients from radiation toxicity.